The ads for the Pfizer painkiller Celebrex feature a man holding a boy’s hand as they walk up a stadium staircase. “52 steps won’t keep you from taking him out to the ballgame,” they say.

But a heart attack would.

Each ad includes a boldface warning that begins, “Important Information: Celebrex may increase the chance of a heart attack or stroke that can lead to death.”

As it resumes ads for the controversial medicine, Pfizer, the world’s biggest drug maker, is offering consumers a decidedly mixed message. But 16 months after the company stopped advertising Celebrex over concerns about its heart risks, Pfizer has returned to the consumer ad market in hopes of reviving sales of the drug, which plunged last year during the ad moratorium.

The new campaign in magazines has raised the ire of consumer groups, who say that Celebrex is so dangerous that Pfizer should stop selling it, not encourage patients to use it.

The campaign is more evidence of the drug industry’s dependence on consumer advertising to prop up sales, said Dr. Sidney Wolfe, a frequent critic of drug makers. “There’s no objective evidence of any unique benefit with this drug, and there is objective evidence of a unique risk,” said Dr. Wolfe, the director of health research for the consumer advocacy group Public Citizen.

Pfizer stopped advertising Celebrex in December 2004, after Merck stopped selling Vioxx, a similar drug, because of its heart dangers. Four months later, federal regulators ordered Pfizer to put a so-called black-box warning on Celebrex, detailing its risks.

In 2004, before the advertising moratorium, Pfizer spent $117 million promoting Celebrex. That year, Celebrex sales were $3.3 billion worldwide. In 2005, during the ad moratorium, sales plunged to $1.7 billion. Pfizer says that all painkillers carry some risk and that its new ads disclose Celebrex’s potential dangers.

“Celebrex has proven to be an important option for many patients,” said Andrew McCormick, a Pfizer spokesman. The Food and Drug Administration has reviewed the new campaign, Mr. McCormick said. Pfizer has not yet decided whether it will expand the campaign to television.

When it was introduced in 1998, Celebrex was thought to be safer for the stomach than older painkillers like naproxen, whose brand name is Aleve. But Celebrex’s stomach benefits have never been proved, and clinical trials have repeatedly linked Celebrex to heart problems. In addition, Celebrex is far more expensive than the older painkillers, costing about $3 a pill, compared with a few cents for naproxen or ibuprofen.

“If it were my money, I wouldn’t pay $2.85 for it,” said Michael Krensavage, a drug industry analyst at Raymond James. “I would try an ibuprofen first.”

We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Bextra, Celebrex MDL judge sets first Bextra trial

On the heels of the $4.85 Billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the...


What is Celebrex? Celebrex is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs)....

Wrongful Death Suit Filed Against Drug Company

A wrongful death lawsuit was filed Monday in Tuscaloosa County against a drug company that makes and...

Celebrex Lawsuit Filed in Tuscaloosa County

The wrongful death complaint was filed in state court by Michael H. Allen, Administrator of the Estate...

Consumer Group says Celebrex Ad Downplays Risks

Pfizer had stopped advertising for the arthritis drug after Merck & Co. Inc.'s rival drug Vioxx was...

Celebrex Blamed for Injuries in Madison County Lawsuit

Celebrex is in the same category as Vioxx, which was recalled by its manufacturer, Merck & Co., on Sept....

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.